Suzanne W J Terheggen-Lagro
Overview
Explore the profile of Suzanne W J Terheggen-Lagro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vonk S, Terheggen-Lagro S, Haarman E, Hashimoto S, Maitland-van der Zee A, Mathot R, et al.
J Cyst Fibros
. 2025 Mar;
PMID: 40089408
Background: The clinical efficacy of elexacaftor-tezacaftor-ivacaftor (ETI) in children with cystic fibrosis (cwCF) is variable; some respond, while others do not or have side effects. The pharmacokinetics (PK) of ETI...
2.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
3.
van Dijk Y, Keuker V, Hashimoto S, Rutjes N, van Muilekom M, Golebski K, et al.
Pediatr Allergy Immunol
. 2024 Oct;
35(10):e14262.
PMID: 39450694
Background: Fatigue is a commonly reported clinical symptom, yet research on fatigue in children with severe asthma is missing. We aimed to explore the extent of fatigue in severe pediatric...
4.
van Boven M, Hutten G, Richardson R, Konigs M, Leemhuis A, Onland W, et al.
Eur Respir Rev
. 2024 Oct;
33(174).
PMID: 39384308
Background: Immature lung development and respiratory morbidity place preterm-born children at high risk of long-term pulmonary sequelae. This systematic review and meta-analysis aims to quantify lung function in preterm-born children...
5.
Lap C, Brackel C, Winkel A, Hashimoto S, Haverkort M, Noij L, et al.
Pediatr Res
. 2024 Sep;
PMID: 39333387
Background: To determine the prevalence of pediatric Post-COVID-19 condition (PPCC), identify risk factors, and assess the quality of life in children with differing severities of acute COVID-19. Methods: During a...
6.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Jul;
PMID: 38954138
No abstract available.
7.
Vonk S, van der Meer-Vos M, Kos R, Neerincx A, Terheggen-Lagro S, Altenburg J, et al.
Ther Drug Monit
. 2024 Jun;
PMID: 38935410
Background: The highly effective Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulator, elexacaftor-tezacaftor-ivacaftor, is now widely being used by people with cystic fibrosis. However, few independent studies have detailed the pharmacokinetics...
8.
van Dijk Y, Brandsen M, Hashimoto S, Rutjes N, Golebski K, Vermeulen F, et al.
Pediatr Pulmonol
. 2024 Jun;
59(11):2875-2884.
PMID: 38934778
Background & Objectives: Despite the availability of biologics for severe pediatric asthma, real-life studies reporting on drivers behind initiating biologics and their alignment with the Global Initiative for Asthma (GINA)...
9.
Tulling A, Holierhoek M, Jansen-Hoogendijk A, Hoste L, Haerynck F, Tavernier S, et al.
Clin Immunol
. 2024 May;
264:110252.
PMID: 38744408
Children with Multisystem Inflammatory Syndrome in Children (MIS-C) can present with thrombocytopenia, which is a key feature of hemophagocytic lymphohistiocytosis (HLH). We hypothesized that thrombocytopenic MIS-C patients have more features...
10.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Apr;
20(7):682-691.
PMID: 38664324
Background: Pediatric post coronavirus disease 2019 (COVID-19) condition (PPCC) is a heterogeneous syndrome, which can significantly affect the daily lives of children. This study aimed to identify clinically meaningful phenotypes...